key: cord-0947313-mpqah0rq
authors: Tiong, Vunjia; Hassandarvish, Pouya; Bakar, Sazaly Abu; Mohamed, Nurul Azmawati; Wan Sulaiman, Wan Shahida; Baharom, Nizam; Abdul Samad, Farishah Nur; Isahak, Ilina
title: The effectiveness of various gargle formulations and salt water against SARS-CoV-2
date: 2021-10-15
journal: Sci Rep
DOI: 10.1038/s41598-021-99866-w
sha: 58b69afe1c4ca8db8e77c0c79eb2303156daca82
doc_id: 947313
cord_uid: mpqah0rq

The COVID-19 is difficult to contain due to its high transmissibility rate and a long incubation period of 5 to 14 days. Moreover, more than half of the infected patients were young and asymptomatic. Virus transmission through asymptomatic patients is a major challenge to disease containment. Due to limited treatment options, preventive measures play major role in controlling the disease spread. Gargling with antiseptic formulation may have potential role in eliminating the virus in the throat. Four commercially available mouthwash/gargle formulations were tested for virucidal activity against SARS-CoV-2 in both clean (0.3 g/l BSA) and dirty (0.3 g/l BSA + 3 mL/L human erythrocytes) conditions at time points 30 and 60 s. The virus was isolated and propagated in Vero E6 cells. The cytotoxicity of the products to the Vero E6 was evaluated by kill time assay based on the European Standard EN14476:2013/FprA1:2015 protocol. Virus titres were calculated as 50% tissue culture infectious dose (TCID50/mL) using the Spearman-Karber method. A reduction in virus titer of 4 log(10) corresponds to an inactivation of ≥ 99.99%. Formulations with cetylperidinium chloride, chlorhexidine and hexitidine achieved > 4 log10 reduction in viral titres when exposed within 30 s under both clean and dirty conditions. Thymol formulations achieved only 0.5 log(10) reduction in viral titres. In addition, salt water was not proven effective. Gargle formulations with cetylperidinium chloride, chlorhexidine and hexetidine have great potential in reducing SAR-CoV-2 at the source of entry into the body, thus minimizing risk of transmission of COVID-19.

| (2021) 11:20502 | https://doi.org/10.1038/s41598-021-99866-w www.nature.com/scientificreports/ Saliva samples of COVID-19 positive patients have been shown to contain live viruses that may cause viral transmission, putting healthcare workers who work in close proximity with the face and oral cavities, like dental professionals, at high risk of acquiring infection 12 . Moreover, usage of ultrasonic and high-speed handpiece instruments generates high amount of blood and salivary aerosols. Indirect contact with contaminated surfaces or instruments also promotes cross-infection 13 . The American Dental Association (ADA) and Centre of Disease Control and Prevention (CDC) have urgently called for dental professionals to use the highest level of infection control since the beginning of this novel coronavirus outbreak. Pre-procedural mouth rinsing (PPMR) has been advocated as a measure to prevent saliva-mediated disease transmission in a dental setting 14 . In accordance with this, the Ministry of Health Malaysia has recommended in its guideline the use of mouthwash containing 1.0-1.5% hydrogen peroxide or 0.2-1.0% povidone iodine prior to dental examination and treatments 15 .

The effectiveness of povidone-iodine (PVP-I) against SARS-CoV-2 has been proven by various studies. An in vivo study among four COVID-19 positive patients suggested that povidone iodine gargling could reduce the saliva viral load of SARS-CoV-2 for at least three hours after gargling 16 . Meanwhile, an in vitro study showed that povidone-iodine mouthwash/gargle/ 1% achieved > 5 log10 reduction in the SARS-CoV-2 titre after at least 15 s of treatment 17 . However, PVP-I is not recommended for those with active thyroid disease, children, pregnancy, patients undergoing radioactive iodine therapy and those with anaphylactic allergy to iodine 18 . It is also costly and not widely available in the market; these factors are important in encouraging uptake of simple preventive measures that the general public can use. Therefore, there is a need to explore other commercial mouthwash formulations, to provide alternatives for the healthcare workers and the public to prevent COVID-19. In this study, we tested four commercially available mouthwash/gargle formulations and salt water against SARS-CoV-2.

Cells and viruses. Vero E6 cells were cultured in Dulbecco's modified Eagle's medium (DMEM) (Gibco, Grand Island, NY, USA) added with 10% fetal bovine serum (FBS) and kept inside CO 2 incubator with 37ºC. Vero E6 was used for virus propagation and titration. TCID50 method used to determine virus titration and it expressed in TCID50/mL. SARS-CoV-2 virus was isolated from nasopharyngeal/oropharyngeal (NP/OP) swab sample from SARS-CoV-2-positive individual. The NP/OP swabs were collected in commercially available virus transport medium which contains antimicrobial agents as stated in the data sheet. Patient characteristics were not recorded for the propagation of the virus. Briefly, the NP/OP sample was inoculated into Vero E6 cells and incubated until visible cytopathic effect. To prevent microbial growth during the propagation of the virus, antibiotics and antimycotics were added to the culture medium during the propagation. The clarified supernatant containing SARS-CoV-2 was harvested as virus stock, titrated by plaque assay, and stored at − 80 °C until further use. The virus stocks prepared (SARS-COV-2/MY/UM/6-3; TIDREC) were confirmed by qPCR prior to use for subsequent experiments (data not shown). All procedures that required handling of live virus was performed in the Biosafety Level 3 (BSL3) laboratory at the Tropical Infectious Diseases Research & Education Centre (TIDREC), Universiti Malaya.

Mouthwash/gargle formulations. Four commercially available mouthwash/gargle formulations and laboratory prepared salt water (2% sodium chloride) were used in this study as shown in Table 1 .

Viral kill time assay. The gargle formulations were tested against SARS-CoV-2 in accordance to the European Standard EN14476:2013/FprA1:2015 protocol as described by Eggers et al. 19 . Briefly, the products were tested under 2 different conditions (interfering substance): clean (0.3 g/l BSA) and dirty (0.3 g/l BSA + 3 mL/L human erythrocytes. The test assay comprised of 100 µl of interfering substance, 100 µl of virus suspension at concentration of 5 × 10 5 TCID50/mL and 800 µl of test product (mouthwash/gargle). After the specified contact time (30 s and 60 s), the virucidal activity of the product was suppressed by a dilution tenfold dilution in ice cold media (DMEM + 2% FBS). Serial dilutions were then prepared and added to Vero E6 cells to determine the TCID50/mL. Virus controls for this test was cell culture medium water in place of test product for both dirty and clean conditions. The cells were incubated for 96 h till obvious CPE developed. 4% paraformaldehyde and 0.5% crystal violet were used to fix and stain the infected cells, respectively. The virus titers were determined using the Spearman-Karber method and expressed TCID50/ml. The virucidal activity was determined by the difference of the logarithmic titer of the virus control minus the logarithmic titer of the test virus (Δ log10 TCID50/ml). A reduction in virus titer of ≥ 4 log10 corresponded to an inactivation of ≥ 99.99% virus. 

Virucidal activity of mouthwash/gargle formulations. The SARS-CoV-2 titre in the control-treated samples under clean and dirty conditions were both at 5.4 × 10 5 TCID50/ml. Cetylperidinium chloride and hexetidine achieved > 5 log10 reduction in viral titers when exposed within 30 s under both clean and dirty conditions. Chlorhexidine digluconate achieved 4 log10 reduction in viral titers within 30 s under both clean and dirty conditions. Salt water and thymol did not show any significant reduction in viral load. (Table 2) . Results from the suppression assay showed no difference in viral titres compared to controls (Table 3) . This suggested that addition of cold media and serial dilution effectively suppressed the product activity, resulting in no reduction of the viral titre.

This study shows that cetylperidinium chloride and hexetidine-containing mouthwash/gargle were able to decrease > 99.99% of SARS-CoV-2 concentration from the initial level after as early as 30 s exposure. Cetylperidinium chloride is a cationic quaternary ammonium compound that is frequently used as detergents and antiseptics 20 . It causes virus inactivation by disrupting the lipid envelope, destroying the capsid, as well as through its lysosomotropic action 21 . This study showed that cetylperidinium chloride in combination with sodium fluoride was very effective in inactivating SARS-CoV-2 after 30 s of contact time. An earlier study demonstrated its efficacy against different strains of influenza viruses 22 . Due to the mechanism of action, it is believed that cetylperinidium may also act effectively against other enveloped viruses such as respiratory syncytial virus (RSV) and parainfluenza.

Hexetidine, has broad spectrum antibacterial and antifungal activities, particularly against gram-positive bacteria and fungi. Hexetidine destructs bacterial cell walls and inhibit oxidative metabolic reactions (thiamine antagonist). Though the antiviral properties was not well studied, it has been shown that hexetidine attenuated highly virulent influenza virus A/H5N1, pandemic influenza virus A/H1N1, respiratory syncytial virus, and herpes simplex virus type 1 after a short-term exposure 23 . Ethanol was known to exert antibacterial and antiviral effect at a minimum concentration of 40-60% 24 . Lower concentration of ethanol in combination with hexetidine in this study may further enhance the antiviral effect against SARS-Cov-2 virus. www.nature.com/scientificreports/ Chlorhexidine mainly acts on bacteria by disrupting bacterial membrane thus increasing membrane permeability that results in cell death and lysis 25 . It is widely used in dentistry for the management bacteria related conditions such as gingivitis and periodontitis 26 and in the intensive care setting for the prevention of nosocomial pneumonia 27 . This study found that the virucidal activity of chlorhexidine containing mouthwash against SARS-CoV-2 was slightly lesser than those of cetylperidinium chloride and hexetidine. This result is incongruent with a study which showed log reduction factors ranging from 0.33 to 0.78 only 28 . However, other recent in vitro and in vivo studies showed that chlorhexidine (0.12% to 2% concentration) was effective against SARS-CoV-2 29, 30 .

Thymol is naturally found in the oils of thyme (Thymus vulgaris L., oregano (Origanum vulgare), Satureja thymbra, Thymbra capitata and Monarda fistulosa L. 31 . Its aqueous extract showed high antiviral activity against HSV-1, HSV-2 and an acyclovir-resistant strain of HSV-1 32 . Thymol in combination with other essential oils had been shown to work effectively against enveloped virus such as influenza A and HSV-1 & 2 but not against non-enveloped viruses namely rotavirus and adenovirus 33 . A recent study also found that a combination of thymol, eucalyptol, menthol and methyl salicylate was effective against SARS-CoV-2 both in-vivo and in-vitro 28, 34 . However, thymol alone showed very minimal virucidal effect (log10 0.5 to 0.75) against SARS-CoV-2 as shown in this study 28 .

Salt water gargling has long been recognised as a popular home remedy to alleviate symptoms for sore throat and colds. An on-going study is examining its effect of COVID-19 symptom relief 37 , but besides that there is little evidence for the antiviral activity of salt water. A study by Lieleg et al. demonstrated that mucin in buffers with high salt concentration (0.3 M) increased the mucin barrier function and could blocked viral infection in vitro 38 . Ramalingam et al. revealed that increasing concentration of sodium chloride (NaCl) enhanced the antiviral activity of epithelial cells through inhibition of RNA and DNA viral replications including human coronavirus 229E 35 . However, this study found that the NaCl solution had no virucidal activity against SARS-CoV-2, even though high concentration of NaCl (0.34 M) was used. More study should be done using various NaCl concentrations to determine the effect of NaCl against SARS-CoV-2.

This is in vitro virucidal activity of mouthwash/gargle formulations against SARS-CoV-2 suggesting that the formulations are able to reduce virus load inside the nasopharynx and oropharynx by targeting virus particles. It is emphasized that the data obtained in this study is applicable to the particular brand of mouthwash/gargle formulations; other products containing the same active ingredients would have to be verified as formulations may vary among different brands. Nonetheless, this study and other recent studies showed that most commercially available mouthwash/gargle formulations were able to inactivate SARS-CoV-2. The most effective active ingredients are povidone-iodine 17 , benzylkonium chloride, essential oils 28 , cetylperidinium chloride and hexetidine.

A number of commercially available mouthwash/gargle formulations containing cetylperidinium chloride and hexetidine demonstrated potent and rapid virucidal activity of ≥ 5 log10 reduction of SARS-CoV-2 at 30 s. Chlorhexidine digluconate was slightly less effective,while salt water and thymol did not show any significant reduction in virus titre. This information gives more options for healthcare workers particularly dentists, anaesthetists, maxillofacial surgeons and otorhinolaryngologists to routinely practice pre-procedural gargling with readily available formulations. The practice of using tested mouthwash/gargle products should also be extended to high-risk groups and the general population to minimize the risk of viral transmission particularly from asymptomatic/presymptomatic carriers. 

World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard

A novel coronavirus from patients with pneumonia in China

COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses

Virological assessment of hospitalized patients with COVID-2019

Insight into 2019 novel coronavirus-An updated intrim review and lessons from SARS-CoV and MERS-CoV

Clinical characteristics and risk factors for severe COVID-19 infections in Malaysia: A nationwide observational study

A review of the preclinical and clinical efficacy of remdesivir, hydroxychloroquine, and lopinavir-ritonavir treatments against COVID-19

Coronavirus disease (COVID-19) advice for the public

Covid-19: PM announces four-week England lockdown

Movement control as an effective measure against Covid-19 spread in Malaysia: An overview

Interim estimates of vaccine effectiveness of Pfizer-BioNTech and Moderna COVID-19 vaccines among health care personnel-33 US Sites

Saliva is a reliable tool to detect SARS-CoV-2

Coronavirus disease 2019 (COVID-19): Emerging and future challenges for dental and oral medicine

Transmission routes of 2019-nCoV and controls in dental practice

Garis Panduan Perkhidmatan Kesihatan Pergigian Pasca Perintah Kawalan Pergerakan Pandemik COVID-19 2/2020

Is povidone iodine mouthwash effective against SARS-CoV-2? First in vivo tests

Povidone iodine gargle and mouthwash

SARS-CoV-2 viral inactivation using low dose povidone-iodine oral rinse-immediate application for the prosthodontic practice

Povidone-iodine hand wash and hand rub products demonstrated excellent in vitro virucidal efficacy against Ebola virus and modified vaccinia virus Ankara, the new European test virus for enveloped viruses

Is the oral cavity relevant in SARS-CoV-2 pandemic?

Repurposing quaternary ammonium compounds as potential treatments for COVID-19

Cetylpyridinium chloride (CPC) exhibits potent, rapid activity against influenza viruses in vitro and in vivo

Analysis of antiviral properties of hexoral in vitro against some viruses that cause acute respiratory infections and herpes

Bactericidal and virucidal activity of ethanol and povidone-iodine

Chlorhexidine gel use in the oral district: A systematic review

Coronavirus pandemic: Is H2O2 mouthwash going to overcome the chlorhexidine in dental practices

Oropharyngeal decontamination with antiseptics to prevent ventilator-associated pneumonia: Rethinking the benefits of chlorhexidine

Virucidal efficacy of different oral rinses against severe acute respiratory syndrome coronavirus 2

Use of chlorhexidine to eradicate oropharyngeal SARS-CoV-2 in COVID-19 patients

Effect of training school teachers on oral hygiene status of 8-10 years old government school children of Udaipur City

Susceptibility ofherpes simplex virus type 1 to monoterpenes thymol, carvacrol, p-cymene and essential oils of Sinapis arvensis L., Lallemantia royleana Benth. and Pulicaria vulgaris Gaertn

Thymus vulgaris L. (Lamiaceae)

The antiviral spectrum of Listerine antiseptic. Oral Surg. Oral Med. Oral Pathol

Early viral clearance among Covid-19 patients when gargling with povidone-iodine and essential oils-A clinical trial

Antiviral innate immune response in non-myeloid cells is augmented by chloride ions via an increase in intracellular hypochlorous acid levels

We would like to thank the Tropical Infectious Disease Research and Education Centre (TIDREC) for usage of the BSL 3 facilities. 

Raw data according to the virus CPE. Number 4 indicating of full CPE in each well and number 0 indicate as healthy cells. Each dilution has 4 replicates.

This study was funded by Universiti Sains Islam Malaysia COVID-19 Fund (PPPI/COVID19_0120/ FPSK/051000/15220) and the Ministry of Education, Malaysia for niche area research under the Higher Institution Centre of Excellence (HICoE) program (Project MO002-2019).

The authors declare no competing interests.

Correspondence and requests for materials should be addressed to N.A.M.Reprints and permissions information is available at www.nature.com/reprints.Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.